Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas System”
1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10889637
Methods of treating an osteolytic tumor and spinal cord injury by administering connexin (Cx) 43 hemichannel-binding antibodies
granted -
US 10888554
Salts of heterocyclic modulators of HIF activity for treatment of disease
granted -
US 10889543
Fine-tune modulators of neuronal excitability for neuropsychiatric disorders
granted -
US 10883094
Transposase polypeptides and uses thereof
granted -
US 10881720
Nanoparticles for immune stimulation
granted -
US 10874631
Altertoxin II as a selective inhibitor of Ewing family of tumor cells
granted -
US 10875920
Antibodies and molecules that immunospecifically bind to BTN1A1 and the therapeutic uses thereof
granted -
US 10874622
Dual assembly nanoparticles
granted -
US 10875912
EGFL6 specific monoclonal antibodies and methods of their use
granted -
US 10869871
Compositions and methods of modulating short-chain dehydrogenase activity
granted -
US 10870854
Inhibitory RNA-based therapeutics targeting ANLN for cancer treatment
granted -
US 10865403
Engineered primate cystine/cysteine degrading enzymes for therapeutic uses
granted -
US 10858432
Antibodies specific to glycosylated PD-1 and methods of use thereof
granted -
US 10858416
Methods and compositions for modification of a HLA locus
granted -
US 10851110
Heterocyclic inhibitors of PTPN11
granted -
US 10849875
Cancer specific lipid targeted peptidomimetics
granted -
US 10851173
Anti-OX40 antibodies and methods of using the same
granted -
US 10842814
Use of low dose arsenic for preserving genomic integrity
granted -
US 10836827
Antibodies specific to glycosylated PD-L1 and methods of use thereof
granted -
US 10837961
Molecular imprinted colored silica beads
granted -
US 10835609
Hydrogels for delivery of therapeutic compounds
granted -
US 10835614
Poly(diol fumarates) and poly(diol fumarate-co-succinates)
granted -
US 10829427
Naphthoquinones, pro-drugs, and methods of use thereof
granted -
US 10821134
BK virus specific T cells
granted